HIV

The AJMC^® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Man rubbing wrist | Image credit: pikselstock - stock.adobe.com

Individuals With HIV Have an Increased Risk of Osteoporosis

By Julia Bonavitacola

September 11th 2025

Bone density was found to be lower in those diagnosed with HIV vs those who were HIV-negative.

Blood donation | Image credit: New Africa - stock.adobe.com

Overall Incidence of HIV in Donated Blood Declined Despite Reduction in Deferral Periods

By Julia Bonavitacola

September 8th 2025

Molecular structure of INSTI | Image credit: Сергей Шиманович - stock.adobe.com

ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy

By Julia Bonavitacola

September 4th 2025

HIV test | Image credit: gamjai - stock.adobe.com

Cotesting for HIV, STIs Improved Screening Practices for HIV

By Julia Bonavitacola

September 2nd 2025

Black woman HIV awareness | Image credit: AS Photo Family - stock.adobe.com

ART Adherence Linked to Patient-Centered Care From Patient-Provider Relationships

By Julia Bonavitacola

August 29th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.

Continuing Medical Education

September 16th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

September 16th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

July 23rd 2014

Entecavir Falls Short of Protecting Hep B-infected Patients from HCC

However, a point to note is that this was a small cohort study without a comparator arm.

July 8th 2014

Patient Advocates Voice Concern Over Drug Benefit Plan Design

Katie Sullivan, MA

The Affordable Care Act (ACA) prohibits insurance companies from rejecting new customers based on their pre-existing health conditions. Yet, a recent report alleged that 4 Florida-based payers may have structured their prescription drug benefit plans in a way which does just that.

June 30th 2014

CDC's Michael Bell to Give Keynote at AJMC Infectious Disease Conference in Atlanta

The American Journal of Managed Care will host a two-day event September 25-26, 2014, in Atlanta taking on some of healthcare's biggest challenges in infectious disease, including HIV, MERS and how to pay for new therapies for hepatitis C. Giving the keynote address will be Michael Bell, MD, deputy director of the Centers for Disease Control and Prevention's Division of Healthcare Quality Promotion.

June 19th 2014

AJMC Sets Infectious Disease Meeting for Atlanta

The American Journal of Managed Care will host a two-day event September 25-26, 2014, to take on some of healthcare's biggest challenges: Treatments that cure hepatitis C are making news but upending balance sheets. A recent recommendation seeks preventive therapy to stop new cases of HIV. Hospitals and public health officials are grappling with how to prevent the spread of MERS. Only AJMC will bring payers, clinicians, policy leaders, and pharmaceutical representatives together to share ideas.

David Alain Wohl, MD, Discusses Strategies to Improve HIV Management

June 9th 2014

David Alain Wohl, MD, Discusses Strategies to Improve HIV Management

David Alain Wohl, MD, associate professor, division of infectious diseases, University of North Carolina at Chapel Hill, suggests that quality management of HIV has, for the most part, been self-regulated. He says that when it comes to HIV management, there is a lack of feedback or "quality improvement mechanisms" outside the managed care setting.

April 23rd 2014

Fauci, Leading AIDS Researchers Discuss Vaccine Prospects in AJMC's Latest 'Evidence-Based' Title

Evidence-Based Immunology and Infectious Disease, the fourth title in the news series from The American Journal of Managed Care, launches with an issue that features interviews with leading AIDS researchers, a discussion of the challenges of paying for breakthrough therapies for hepatitis C, and new information on causes and treatments for rheumatoid arthritis.

April 22nd 2014

Coinfection With HCV Worsens the Condition of HIV Patients Receiving Antiretrovirals

Surabhi Dangi-Garimella, PhD

April 22nd 2014

PBM Reports High Usage of HIV, HCV Drugs Among ACA Clients

Mary K. Caffrey

April 22nd 2014

Increasing Access to HIV Care May Help Improve Outcomes

Marj P. Zimmerman, BSPharm, MS Stanton R. Mehr

April 22nd 2014

Fauci: Advances in HIV Therapy Have Saved Lives, but Vaccine Still Needed

Tracey L. Regan

April 21st 2014

The Hunt for the 'Most Satisfying Solution': Fauci, Researchers Discuss Search For AIDS Vaccine

Tracey L. Regan

April 9th 2014

Early Drug Claims Suggest Exchange Plan Enrollees Are Sicker Than Average

Offering a first glimpse of the health care needs of Americans who bought coverage through federal and state marketplaces, an analysis of the first two months of claims data shows the new enrollees are more likely to use expensive specialty drugs to treat conditions like HIV/AIDS and hepatitis C than those with job-based insurance.

Segment 8 - Future of Innovation and Treatment Costs

February 18th 2014

Segment 8 - Future of Innovation and Treatment Costs

In the concluding segment, Dr Fendrick asks the panel to provide closing remarks about the future of treating hepatitis C (HCV). Dr Afdal says he believes this is a moment in time where a revolution is taking place.

September 30th 2013

Participating Faculty: Addressing Adherence Challenges Associated With Antiretroviral Therapy: Focus on Noninfectious Diarrhea

July 1st 2013

HIV/AIDS Patients Recommended Earlier Intervention

July 23rd 2012

Global AIDS Conference Rally Calls for Cheaper Medicines, More Funding

July 17th 2012

Deciding On Truvada: Who Should Take A HIV Prevention Pill?

July 5th 2012

Rapid H.I.V. Home Test Wins Federal Approval

May 11th 2012

FDA Panel Says Yes to HIV Prevention Pill

May 3rd 2012

More Than 100 Are Charged in Medicare Fraud Sweep

April 26th 2012

HIV/AIDS Activists Hoping Anxiously that Healthcare Law Survives Supreme Court Review

March 5th 2012

Good, Bad HIV News About Injection Drug Users

February 20th 2012

Model Explains Efficacy of HIV Drugs

February 10th 2012

FDA: HCV Drug Interferes With HIV Meds

January 10th 2012

HHS Plans HIV Clinician Workforce Study

December 20th 2011

Dr. William A. O'Brien Discusses the Cost of Advancing HIV Treatments

...

28 29 30 31 32 33 >

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions